Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
990EZ • Fiscal year 2020 • EIN 82-3268952
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
91st percentile
Higher net margin than 91% of similar nonprofits.
Top Officer Pay
76th percentile
Higher top officer pay than 76% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
$52,610
No earlier filing loaded for comparison.
Net Assets
$52,610
No earlier filing loaded for comparison.
Liabilities
-
No earlier filing loaded for comparison.
Revenue
$63,948
No earlier filing loaded for comparison.
Expenses
$27,788
No earlier filing loaded for comparison.
Net Income
$36,160
No earlier filing loaded for comparison.
Destroy duchennes mission is to complete the cure for duchenne muscular dystrophy by advancing gene-editing and gene therapy technologies, the future of medicine, into human practice.
| Description | Grants | Expenses |
|---|---|---|
| OUR FOUNDER, ELIJAH STACY WHO IS 19 YEARS OLD, HAS TAKEN AN ENTIRE YEAR TO WRITE A 100K WORD AUTOBIOGRAPHY ABOUT HIS LIFE LIVING WITH DUCHENNE AND SOME OF THE LIFE LESSONS HE HAS LEARNED BECAUSE OF IT. THIS BOOK GIVES AN HONEST AND EVEN VULNERABLE LOOK INTO WHAT LIFE IS REALLY LIKE LIVING WITH DUCHENNE MUSCULAR DYSTROPHY. BY PROPERLY LAUNCHING AND PUBLICIZING THE BOOK/ELIJAH'S STORY, WE BELIEVE WE CAN SOLVE THE AWARENESS PROBLEM SURROUNDING DUCHENNE MUSCULAR DYSTROPHY. WE BELIEVE THIS WILL LEAD TO MORE DRUGS BEING PASSED BY THE FDA BECAUSE OF A DEEPER PERSONAL UNDERSTANDING OF DUCHENNE AND WE BELIEVE IT WILL ALLOW US TO RAISE MORE FUNDS TO ACCOMPLISH OUR MISSION: COMPLETE THE CURETM FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE. | - | $22,750 |
| WITH THE DEVELOPMENT AND RISE OF GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY TO CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY TO REWRITE OUR DNA AND CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS FOR GENE EDITING TO IMPROVE THE WORLD ARE NEARLY ENDLESS AND WE WANT TO BE THE CHAMPION OF ADVANCING GENE EDITING TO HUMAN TRIALS FOR PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE OF GENE EDITING TECHNOLOGY, CRISPR-CAS9, IS THE TOOL TO CURE DUCHENNE THAT NEEDS TO BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED TO BE DONE TO PERFECT THIS TOOL, CRISPR-CAS9, AND THAT IS WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE. | - | $4,374 |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| LINDA WHITE | President | - | $0 | - | - |
| JOSHUA SPIEGEL | Vice Preside | - | $0 | - | - |
| DAN LANG | Treasurer | - | $0 | - | - |
| VICKI SUTHERLAND | Secretary | - | $0 | - | - |
| ADRIANA MAGALLANES | Director | - | $0 | - | - |
| MIGUEL ESTRADA | Director | - | $0 | - | - |
“Expenses advertising 230 promotional merchandise 1,233 bank fees 12 merchant fees 27 computer expense 991 website 596 equipment expense 1,324 licenses fee 625 total 5,038”
“Destroy duchennes mission is to complete the cure for duchenne muscular dystrophy by advancing gene-editing and gene therapy technologies, the future of medicine, into human practice.”
“With the development and rise of gene editing, crispr-cas9, technologies, humanity has a real opportunity to cure virtually all genetic diseases, such as duchenne muscular dystrophy. Gene editing technology has given us the ability to rewrite our dna and correct faulty dna, like mutations that cause diseases. The applications for gene editing to improve the world are nearly endless and we want to be the champion of advancing gene editing to human trials for people with duchenne. It could be said that the current state of gene editing technology, crispr-cas9, is the tool to cure duchenne that needs to be perfected before it can be applied in humans. More scientific studies need to be done to perfect this tool, crispr-cas9, and that is why we so passionately say we need to: complete the cure.”
“Our founder, elijah stacy who is 19 years old, has taken an entire year to write a 100k word autobiography about his life living with duchenne and some of the life lessons he has learned because of it. This book gives an honest and even vulnerable look into what life is really like living with duchenne muscular dystrophy. By properly launching and publicizing the book/elijah's story, we believe we can solve the awareness problem surrounding duchenne muscular dystrophy. We believe this will lead to more drugs being passed by the fda because of a deeper personal understanding of duchenne and we believe it will allow us to raise more funds to accomplish our mission: complete the curetm for duchenne muscular dystrophy by advancing gene-editing and gene therapy technologies, the future of medicine, into human practice.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 0 | LINDA WHITE |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 1 | JOSHUA SPIEGEL |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 2 | DAN LANG |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 3 | VICKI SUTHERLAND |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 4 | ADRIANA MAGALLANES |
| CompensationExplanation/CompensationExplanationGrp/PersonNm | 5 | MIGUEL ESTRADA |
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | SACKETT FINANCIAL GROUP |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 7146719330 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 915 W IMPERIAL HIGHWAY 160 |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | BREA |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92821 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 16450 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 52610 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 63948 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 36160 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 16450 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 52610 |
| IRS990EZ/GrossReceiptsAmt | 0 | 63948 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 16450 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 52610 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 16450 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 52610 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | LINDA WHITE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | JOSHUA SPIEGEL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | DAN LANG |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | VICKI SUTHERLAND |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | ADRIANA MAGALLANES |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | MIGUEL ESTRADA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | PRESIDENT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | VICE PRESIDE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | TREASURER |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | SECRETARY |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | DIRECTOR |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 5038 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | DESTROY DUCHENNES MISSION IS TO COMPLETE THE CURE FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE. |
| IRS990EZ/PrintingPublicationsPostageAmt | 0 | 22750 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | WITH THE DEVELOPMENT AND RISE OF GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY TO CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY TO REWRITE OUR DNA AND CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS FOR GENE EDITING TO IMPROVE THE WORLD ARE NEARLY ENDLESS AND WE WANT TO BE THE CHAMPION OF ADVANCING GENE EDITING TO HUMAN TRIALS FOR PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE OF GENE EDITING TECHNOLOGY, CRISPR-CAS9, IS THE TOOL TO CURE DUCHENNE THAT NEEDS TO BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED TO BE DONE TO PERFECT THIS TOOL, CRISPR-CAS9, AND THAT IS WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 1 | OUR FOUNDER, ELIJAH STACY WHO IS 19 YEARS OLD, HAS TAKEN AN ENTIRE YEAR TO WRITE A 100K WORD AUTOBIOGRAPHY ABOUT HIS LIFE LIVING WITH DUCHENNE AND SOME OF THE LIFE LESSONS HE HAS LEARNED BECAUSE OF IT. THIS BOOK GIVES AN HONEST AND EVEN VULNERABLE LOOK INTO WHAT LIFE IS REALLY LIKE LIVING WITH DUCHENNE MUSCULAR DYSTROPHY. BY PROPERLY LAUNCHING AND PUBLICIZING THE BOOK/ELIJAH'S STORY, WE BELIEVE WE CAN SOLVE THE AWARENESS PROBLEM SURROUNDING DUCHENNE MUSCULAR DYSTROPHY. WE BELIEVE THIS WILL LEAD TO MORE DRUGS BEING PASSED BY THE FDA BECAUSE OF A DEEPER PERSONAL UNDERSTANDING OF DUCHENNE AND WE BELIEVE IT WILL ALLOW US TO RAISE MORE FUNDS TO ACCOMPLISH OUR MISSION: COMPLETE THE CURETM FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 4374 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 1 | 22750 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 27788 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 27124 |
| IRS990EZ/TotalRevenueAmt | 0 | 63948 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.DESTROYDUCHENNE.ORG |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 63948 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 63948 |
| IRS990ScheduleA/PublicOrganization170Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 1.00000 |
| IRS990ScheduleA/PublicSupportTotal170Amt | 0 | 63948 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind | 0 | X |
| IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt | 0 | 63948 |
| IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt | 0 | 63948 |
| IRS990ScheduleA/TotalSupportAmt | 0 | 63948 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES ADVERTISING 230 PROMOTIONAL MERCHANDISE 1,233 BANK FEES 12 MERCHANT FEES 27 COMPUTER EXPENSE 991 WEBSITE 596 EQUIPMENT EXPENSE 1,324 LICENSES FEE 625 TOTAL 5,038 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | DESTROY DUCHENNES MISSION IS TO COMPLETE THE CURE FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | WITH THE DEVELOPMENT AND RISE OF GENE EDITING, CRISPR-CAS9, TECHNOLOGIES, HUMANITY HAS A REAL OPPORTUNITY TO CURE VIRTUALLY ALL GENETIC DISEASES, SUCH AS DUCHENNE MUSCULAR DYSTROPHY. GENE EDITING TECHNOLOGY HAS GIVEN US THE ABILITY TO REWRITE OUR DNA AND CORRECT FAULTY DNA, LIKE MUTATIONS THAT CAUSE DISEASES. THE APPLICATIONS FOR GENE EDITING TO IMPROVE THE WORLD ARE NEARLY ENDLESS AND WE WANT TO BE THE CHAMPION OF ADVANCING GENE EDITING TO HUMAN TRIALS FOR PEOPLE WITH DUCHENNE. IT COULD BE SAID THAT THE CURRENT STATE OF GENE EDITING TECHNOLOGY, CRISPR-CAS9, IS THE TOOL TO CURE DUCHENNE THAT NEEDS TO BE PERFECTED BEFORE IT CAN BE APPLIED IN HUMANS. MORE SCIENTIFIC STUDIES NEED TO BE DONE TO PERFECT THIS TOOL, CRISPR-CAS9, AND THAT IS WHY WE SO PASSIONATELY SAY WE NEED TO: COMPLETE THE CURE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | OUR FOUNDER, ELIJAH STACY WHO IS 19 YEARS OLD, HAS TAKEN AN ENTIRE YEAR TO WRITE A 100K WORD AUTOBIOGRAPHY ABOUT HIS LIFE LIVING WITH DUCHENNE AND SOME OF THE LIFE LESSONS HE HAS LEARNED BECAUSE OF IT. THIS BOOK GIVES AN HONEST AND EVEN VULNERABLE LOOK INTO WHAT LIFE IS REALLY LIKE LIVING WITH DUCHENNE MUSCULAR DYSTROPHY. BY PROPERLY LAUNCHING AND PUBLICIZING THE BOOK/ELIJAH'S STORY, WE BELIEVE WE CAN SOLVE THE AWARENESS PROBLEM SURROUNDING DUCHENNE MUSCULAR DYSTROPHY. WE BELIEVE THIS WILL LEAD TO MORE DRUGS BEING PASSED BY THE FDA BECAUSE OF A DEEPER PERSONAL UNDERSTANDING OF DUCHENNE AND WE BELIEVE IT WILL ALLOW US TO RAISE MORE FUNDS TO ACCOMPLISH OUR MISSION: COMPLETE THE CURETM FOR DUCHENNE MUSCULAR DYSTROPHY BY ADVANCING GENE-EDITING AND GENE THERAPY TECHNOLOGIES, THE FUTURE OF MEDICINE, INTO HUMAN PRACTICE. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART III, LINE 28 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III, LINE 29 |
| ReturnHeader/BuildTS | 0 | 2022-09-23 18:48:47Z |
| ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd | 0 | true |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | DAN LANG |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | TREASURER |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 9514448147 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2021-07-19 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | DESTROY DUCHENNE |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | DEST |
| ReturnHeader/Filer/EIN | 0 | 823268952 |
| ReturnHeader/Filer/PhoneNum | 0 | 9514448147 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 3182 VANDERMOLEN DR |
| ReturnHeader/Filer/USAddress/CityNm | 0 | NORCO |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92860 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 330946321 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | SACKETT FINANCIAL GROUP |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 915 W IMPERIAL HWY STE 160 |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | BREA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 92821 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 7146719330 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2021-07-19 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | BRAID DEWEESE CPA |
| ReturnHeader/ReturnTs | 0 | 2021-07-22T14:52:48-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | DAN |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | LANG |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2020-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2020-12-31 |
| ReturnHeader/TaxYr | 0 | 2020 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2020 • Form 990EZDetailed filing. Detailed filing data is available for this year.